SCHEMBL28645488

SCHEMBL28645488

COC(=O)c1ccc(CN(C(=O)N2CCSCC2)c2ccc(F)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
PDK1 Q15118 2/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
PDE6D O43924 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28633973 0.89 CA1 (0.46) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL28923946 0.89 ALDH1A1 (0.46) MAPK1NPC1RAB9AMAPTPDK2
SCHEMBL28634158 0.89 ALDH1A1 (0.41) MAPK1NPC1RAB9AMAPTHTT
SCHEMBL22218102 0.88 MAPK1 (0.44) MAPK1KMT2AMEN1NPC1RAB9A
SCHEMBL28630192 0.88 LTB4R2 (0.43) KMT2AMEN1NPC1RAB9AMAPT
SCHEMBL28647144 0.87 CA1 (0.46) MAPK1NPC1MAPTSMN1; SMN2KDM4E
SCHEMBL28637466 0.87 PTGES (0.43) KMT2AMEN1RAB9AMAPTLTB4R2
SCHEMBL20236729 0.87 ALDH1A1 (0.51) MAPK1KMT2AMEN1NPC1RAB9A
SCHEMBL20236478 0.87 MAPK1 (0.43) MAPK1KMT2AMEN1NPC1RAB9A
SCHEMBL20236232 0.87 KDM4E (0.46) MAPK1KMT2AMEN1MAPTPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137518-B 1,3, 4-oxadiazole derivative compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same 株式会社钟根堂 2021-08-31 CN disclosed